This is a compilation of the slides presented at the University College Hospital Ibadan, Nigeria, which entails the literature review, epidemiology, case study on Hepatitis and associated disease conditions.
This also explains the significance of Pharmacists in improving adherence to therapeutic regimens, understanding of the risk factors and various predispositions to liver diseases, the cost-effectiveness, cost-benefits analysis, and the medication therapy management in the assessment of Heaptic Diseases.
Ala, O. (2022). Hepatitis B/ Hepatitis C/ Decompensated Hepatic Disease/ Cirrhotic Disease of the Liver. Afribary. Retrieved from https://track.afribary.com/works/hepatitis-and-related-diseases
Ala, Oluwafemi "Hepatitis B/ Hepatitis C/ Decompensated Hepatic Disease/ Cirrhotic Disease of the Liver" Afribary. Afribary, 26 Oct. 2022, https://track.afribary.com/works/hepatitis-and-related-diseases. Accessed 27 Nov. 2024.
Ala, Oluwafemi . "Hepatitis B/ Hepatitis C/ Decompensated Hepatic Disease/ Cirrhotic Disease of the Liver". Afribary, Afribary, 26 Oct. 2022. Web. 27 Nov. 2024. < https://track.afribary.com/works/hepatitis-and-related-diseases >.
Ala, Oluwafemi . "Hepatitis B/ Hepatitis C/ Decompensated Hepatic Disease/ Cirrhotic Disease of the Liver" Afribary (2022). Accessed November 27, 2024. https://track.afribary.com/works/hepatitis-and-related-diseases